...
首页> 外文期刊>Journal of Medical Virology >Correlation Between The Promoter Basal Core and Precore Mutations and HBsAg Quantification in French Blood Donors Infected With Hepatitis B Virus
【24h】

Correlation Between The Promoter Basal Core and Precore Mutations and HBsAg Quantification in French Blood Donors Infected With Hepatitis B Virus

机译:法国乙型肝炎病毒感染者的启动子基础核心和前核心突变与HBsAg定量的相关性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatitis B virus (HBV) basal core promoter (BCP) and precore (PC) mutations, HBV viral load and HBV surface antigen (HBsAg) quantitation were screened to assess correlations between these HBV markers in asymptomatic chronic hepatitis B carriers in France. From January 2006 to July 2007, 200 sera were collected from patients who were discovered to be HBsAg-positive when they volunteered to give blood. Direct sequencing of precore/core gene was used to detect A1762T/G1764A mutations in the BCP and G1896A in the PC region. HBV viral load and HBsAg were quantified with two commercials assays. The prevalence of the BCP and PC mixed/mutants were 37% and 60% respectively (P=0.0001). HBV DNA level and HBsAg titer were significantly lower in subjects harboring the mixed/mutant PC virus compared to those infected by the wild phenotype. No significant difference was observed in HBV viral loads of blood donors infected by wild or mixed/mutant BCP viruses. Mutant or mixed PC virus was associated with male gender, HBeAb-positive status and HBV/D and HBV/E genotypes. BCP mutations were associated with age, and both HBV/A-HBV/E genotypes.The genetic properties of HBV in this cohort showed that most of the blood donors had a negative HBeAg serological status and harbored the PC mutant phenotype in combination with low levels of both HBV DNA and HBsAg. As the study was conducted in healthy subjects who could be considered as asmptomatic carriers, these results suggest a possible protective effect of the G1896A mutation against severe liver lesions. J. Med. Virol. 87:529-535, 2015. (c) 2014 Wiley Periodicals, Inc.
机译:筛选了乙型肝炎病毒(HBV)基础核心启动子(BCP)和前核(PC)突变,HBV病毒载量和HBV表面抗原(HBsAg)定量,以评估法国无症状慢性乙型肝炎携带者中这些HBV标记之间的相关性。从2006年1月至2007年7月,从自愿献血时被发现为HBsAg阳性的患者中收集了200份血清。前核心/核心基因的直接测序用于检测PC区域BCP和G1896A中的A1762T / G1764A突变。 HBV病毒载量和HBsAg用两种商品化验方法定量。 BCP和PC混合/突变的患病率分别为37%和60%(P = 0.0001)。与受到野生表型感染的受试者相比,携带混合/突变PC病毒的受试者的HBV DNA水平和HBsAg滴度显着降低。在野生或混合/突变的BCP病毒感染的献血者的HBV病毒载量中没有观察到显着差异。突变或混合型PC病毒与男性,HBeAb阳性状态以及HBV / D和HBV / E基因型有关。 BCP突变与年龄以及HBV / A-HBV / E基因型相关。在该队列中HBV的遗传学特征表明,大多数献血者的HBeAg血清学状况均为阴性,并且携带PC突变表型并伴有低水平HBV DNA和HBsAg的含量。由于这项研究是在健康受试者中进行的,他们被认为是无症状的携带者,因此这些结果表明G1896A突变可能对严重的肝脏病变具有保护作用。 J. Med。病毒。 87:529-535,2015.(c)2014威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号